Average Co-Inventor Count = 6.71
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (26 from 666 patents)
2. Incyte Holdings Corporation (10 from 147 patents)
3. Pfizer Corporation (1 from 4,455 patents)
27 patents:
1. 12415809 - Pyrrolotriazine compounds as tam inhibitors
2. 12201636 - Heterocyclylamines as PI3K inhibitors
3. 11851442 - Tricyclic fused thiophene derivatives as JAK inhibitors
4. 11433071 - Heterocyclylamines as PI3K inhibitors
5. 11161855 - Tricyclic fused thiophene derivatives as JAK inhibitors
6. 11136326 - Pyrrolopyrimidine derivatives as TAM inhibitors
7. 10646492 - Heterocyclylamines as PI3K inhibitors
8. 10640506 - Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors
9. 10519163 - Pyrrolopyrimidine derivatives as TAM inhibitors
10. 10092570 - Heterocyclylamines as PI3K inhibitors
11. 10053465 - Pyrrolopyrimidine derivatives as TAM inhibitors
12. 9908895 - Tricyclic fused thiophene derivatives as JAK inhibitors
13. 9730939 - Heterocyclylamines as PI3K inhibitors
14. 9334274 - N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
15. 9193733 - Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors